Blood eMTBR-tau linked to Alzheimer’s tangles at autopsy
Classification accuracy remained high (AUC=0.91–0.95) up to a decade before death, with higher sensitivity and specificity than plasma p-tau217.
medRxiv
In people whose brains were examined at autopsy, blood eMTBR-tau was strongly associated with Alzheimer neuropathologic change. Researchers tested an immunoassay that measures an endogenously cleaved fragment of tau protein. The marker predominantly reflected tangle burden and anatomical progression, but not amyloid plaque load. It classified Braak stages and Alzheimer neuropathologic change more accurately than plasma p-tau217, even with blood collected up to a decade before death.
Higher baseline eMTBR-tau was also associated with worse cognition and predicted faster cognitive worsening. Researchers replicated the findings in a separate living cohort assessed with tangle and plaque neuroimaging. In that cohort, concordance between plasma eMTBR-tau and tau imaging reached up to 94%, suggesting potential as a surrogate marker.
Why it matters
The findings suggest that a blood assay may support earlier detection, biological staging and prognosis of Alzheimer’s disease over a prolonged window before death.
Caveats
This observational study does not establish clinical utility or validate the assay as a replacement for tau imaging. It is a preprint and has not yet been peer-reviewed.
The paper
Show 10 more authors
M. N. Nafash, D. S. Smirnov, M. I. Kamboh, B. Snitz, J. K. Kofler, A. D. Cohen, T. A. Pascoal, M. D. Ikonomovic, H. Zetterberg, O. Lopez,University of Pittsburgh
medRxiv · 5 Oct 2026 · CC BY · Preprint, not peer-reviewed
